Colonic cancer and polyps

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 1, 2002, Pages 91-114

  Schulmann, Karsten ^a   Reiser, Markus ^a   Schmiegel, Wolff ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

APC; Chemoprevention; Colonoscopy, FOBT; Colorectal adenoma; Colorectal carcinoma; CRC screening; FAP; HNPCC; Juvenile polyposis; MMR genes; Peutz Jeghers; Polyposis

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CELECOXIB; ESTROGEN; FLUOROURACIL; FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SULINDAC;

ADENOMATOUS POLYP; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CAUSE OF DEATH; CLINICAL TRIAL; COLON POLYP; COLON POLYPOSIS; COLORECTAL CANCER; EARLY DIAGNOSIS; GENDER; HUMAN; PEUTZ JEGHERS SYNDROME; PRECANCER; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; AGED; COLON TUMOR; COLORECTAL TUMOR; FEMALE; MALE; MASS SCREENING; BLOOD ANALYSIS; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER RISK; CANCER SURGERY; CLINICAL FEATURE; COLON BIOPSY; COLON RESECTION; DISEASE ASSOCIATION; ENDOSCOPIC POLYPECTOMY; FAMILIAL CANCER; ILEORECTAL ANASTOMOSIS; JUVENILE POLYP; OCCULT BLOOD; PROCTOCOLECTOMY;

ADENOMATOUS POLYPOSIS COLI; AGED; COLONIC NEOPLASMS; COLONIC POLYPS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; MALE; MASS SCREENING; PEUTZ-JEGHERS SYNDROME;

EID: 0036483392     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0268     Document Type: Article

References (82)

1. WHO. Pathology and Genetics of Tumours of the Digestive System Lyon: IARC Press 2000
2. Zauber, A G, & Winawer, S J (1997). Initial management and follow-up surveillance of patients with colorectal adenomas. Gastroenterology Clinics of North America, 26 85-101.
3. Willett, W C, Stampfer, M J, Colditz, G A et al. (1990). Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. New England Journal of Medicine, 323 1664-1672.
4. Giovannucci, E, Stampfer, M J, Colditz, G et al. (1992). Relationship of diet to risk of colorectal adenoma in men. Journal of the National Cancer Institute, 84 91-98.
5. Pretlow, T P, Barrow, B J, Ashton, W S et al. (1991). Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Research, 51 1564-1567.
6. Jass, J R, & Sobin, L H (1989). Histological typing of intestinal tumours. WHO International Histological Classification of Tumours, : Berlin Heidelberg, New York, Tokyo: Springer.
7. Vogelstein, B, Fearon, E R, Hamilton, S R et al. (1988). Genetic alterations during colorectal-tumor development. New England Journal of Medicine, 319 525-532.
8. Watanabe, T, Wu, T T, Catalano, P J et al. (2001). Molecular predictors of survival after adjuvant chemotherapy for colon cancer. New England Journal of Medicine, 344 1196-1206.
9. Mandel, J S, Church, T R, Bond, J H et al. (2000). The effect of fecal occult-blood screening on the incidence of colorectal cancer. New England Journal of Medicine, 343 1603-1607.
10. Lieberman, D A, Weiss, D G, Bond, J H et al. (2000). Use of colonoscopy to screen asymptomatic adults for colorectal cancer. New England Journal of Medicine, 343 162-168.
11. Imperiale, T F, Wagner, D R, Lin, C Y et al. (2000). Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. New England Journal of Medicine, 343 169-174.
12. Burt, R W (2000). Colon cancer screening. Gastroenterology, 119 837-853.
13. Lynch, H T (1999). Hereditary nonpolyposis colorectal cancer (HNPCC). Cytogenetics and Cell Genetics, 86 130-135.
14. Vasen, H F, Watson, P, Mecklin, J P et al. (1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 116 1453-1456.
15. Kinzler, K W, Nilbert, M C, Su, L K et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science, 253 661-665.
16. Offerhaus, G J, Giardiello, F M, Krush, A J et al. (1992). The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology, 102 1980-1982.
17. Caspari, R, Friedl, W, Boker, T et al. (1993). Predictive diagnosis in familial adenomatous polyposis: evaluation of molecular genetic and ophthalmologic methods. Zeitschrift fur Gastroenterologie, 31 646-652.
18. Lynch, H T, Smyrk, T C, Watson, P et al. (1992). Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis?. Diseases of the Colon and Rectum, 35 411-421.
19. Spirio, L, Olschwang, S, Groden, J et al. (1993). Alleles of the APC gene: an attenuated form of familial polyposis. Cell, 75 951-957.
20. Brensinger, J D, Laken, S J, Luce, M C et al. (1998). Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene. Gut, 43 548-552.
21. Friedl, W, Caspari, R, Sengteller, M et al. (2001). Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut, 48 515-521.
22. Wallis, Y L, Morton, D G, McKeown, C M et al. (1999). Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. Journal of Medical Genetics, 36 14-20.
23. Olschwang, S, Tiret, A, Laurent-Puig, P et al. (1993). Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell, 75 959-968.
24. Eccles, D M, van der Luijt, R, Breukel, C et al. (1996). Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. American Journal of Human Genetics, 59 1193-1201.
25. Bertario, L, Russo, A, Radice, P et al. (2000). Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry. Annals of Surgery, 231 538-543.
26. Bulow, C, Vasen, H, Järvinen, H et al. (2000). Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology, 119 1454-1460.
27. Schmiegel, W, Adler, G, Frühmorgen, P et al. (2000). Kolorektales Karzinom: Prävention und Früherkennung in der asymptomatischen Bevölkerung - Vorsorge bei Risikopatienten - Endoskopische Diagnostik, Therapie und Nachsorge von Polypen und Karzinomen. Zeitschrift for Gastroenterologie, 38 49-75.
28. Vasen, H F, & Bulow, S and the Leeds Castle Polysis Group (2001). Guidelines for the management of familial adenomatous polyposis (FAP): a world wide survey among 41 registrics. Colorectal Diseases, 1 214-221.
29. Spigelman, A D, Murday, V, & Phillips, R K (1989). Cancer and the Peutz-Jeghers syndrome. Gut, 30 1588-1590.
30. Heiskanen, I, & Jarvinen, H J (1997). Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. International Journal of Colorectal Disease, 12 9-13.
31. Giardiello, F M, & Offerhaus, J G (1995). Phenotype and cancer risk of various polyposis syndromes. Cancer, 31A 1085-1087.
32. Steinbach, G, Lynch, P M, Phillips, R K et al. (2000). The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. New England Journal of Medicine, 342 1946-1952.
33. Aaltonen, L A, Salovaara, R, Kristo, P et al. (1998). Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. New England Journal of Medicine, 338 1481-1487.
34. Watson, P, Lin, K M, Rodriguez-Bigas, M A et al. (1998). Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer, 83 259-266.
35. Hamilton, S R, Liu, B, Parsons, R E et al. (1995). The molecular basis of Turcot's syndrome. New England Journal of Medicine, 332 839-847.
36. Kolodner, R D, Hall, N R, Lipford, J et al. (1994). Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics, 24 516-526.
37. Bapat, B, Xia, L, Madlensky, L, Mitri, A et al. (1996). The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. American Journal of Human Genetics, 59 736-739.
38. Vasen, H F, Mecklin, J P, Khan, P M et al. (1991). The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Diseases of the Colon and Rectum, 34 424-425.
39. Rodriguez-Bigas, M A, Boland, C R, Hamilton, S R et al. (1997). A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. Journal of the National Cancer Institute, 89 1758-1762.
40. Aaltonen, L A, Peltomäki, P, Mecklin, J P et al. (1994). Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Research, 54 1645-1648.
41. Liu, B, Parsons, R, Papadopoulos, N et al. (1996). Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Medicine, 2 169-174.
42. Kolodner, R D, Tytell, J D, Schmeits, J L et al. (1999). Germ-line msh6 mutations in colorectal cancer families. Cancer Research, 59 5068-5074.
43. Wu, Y, Berends, M J, Mensink, R G et al. (1999). Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. American Journal of Human Genetics, 65 1291-1298.
44. Wijnen, J, de Leeuw, W, Vasen, H et al. (1999). Familial endometrial cancer in female carriers of MSH6 germline mutations. Nature Genetics, 23 142-144.
45. Akiyama, Y, Sato, H, Yamada, T et al. (1997). Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Research, 57 3920-3923.
46. Miyaki, M, Konishi, M, Tanaka, K et al. (1997). Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Genetics, 17 271-272.
47. Vasen, H F, Wijnen, J T, Menko, F H et al. (1996). Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 110 1020-1027.
48. Dunlop, M G, Farrington, S M, Carothers, A D et al. (1997). Cancer risk associated with germline DNA mismatch repair gene mutations. Human Molecular Genetics, 6 105-110.
49. Järvinen, H J, Aarnio, M, Mustonen, H et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118 829-834.
50. Vasen, H F, Nagengast, F M, & Khan, P M (1995). Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet, 345 1183-1184.
51. Tomlinson, I P, & Houlston, R S (1997). Peutz-Jeghers syndrome. Journal of Medical Genetics, 34 1007-1011.
52. Hemminki, A, Markie, D, Tomlinson, I et al. (1998). A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature, 391 184-187.
53. Jenne, D E, Reinmann, H, Nezu, J et al. (1998). Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nature Genetics, 18 38-43.
54. Gruber, S B, Entius, M M, Petersen, G M et al. (1998). Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Research, 58 5267-5270.
55. Hizawa, K, Iida, M, Matsumoto, T et al. (1993). Neoplastic transformation arising in Peutz-Jeghers polyposis. Diseases of the Colon and Rectum, 36 953-957.
56. Giardiello, F M, Brensinger, J D, Tersmette, A C et al. (2000). Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology, 119 1447-1453.
57. Boardman, L A, Thibodeau, S N, Schaid, D J et al. (1998). Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Annals of Internal Medicine, 128 896-899.
58. Scully, R E (1970). Sex cord tumor with annular tubules: a distinctive ovarian tumor of the Peutz-Jeghers syndrome. Cancer, 25 1107-1121.
59. Coen, P, Kulin, H, Ballantine, T et al. (1991). An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. New England Journal of Medicine, 324 317-322.
60. Pennazio, M, & Rossini, F P (2000). Small bowel polyps in Peutz-Jeghers syndrome: management by combined push enteroscopy and intraoperative enteroscopy. Gastrointestinal Endoscopy, 51 304-308.
61. Rossini, F P, Arrigoni, A, & Pennazio, M (1996). Clinical enteroscopy. Journal of Clinical Gastroenterology, 22 231-235.
62. Höfting, I, Pott, G, & Schrameyer, B et al. (1993). Familial juvenile Polyposis mit prädominanter Magenbeteiligung. Zeitschrift fur Gastroenterologie, 31 480-483.
63. Howe, J R, Ringold, J C, Summers, R W et al. (1998). A gene for familial juvenile polyposis maps to chromosome 18q21.1. American Journal of Human Genetics, 62 1129-1136.
64. Olschwang, S, Serova-Sinilnikova, O M, Lenoir, G M et al. (1998). PTEN germ-line mutations in juvenile polyposis coli. Nature Genetics, 18 12-14.
65. Eng, C, & Peacocke, M (1998). PTEN and inherited hamartoma-cancer syndromes. Nature Genetics, 19 223.
66. Howe, J R, Bair, J L, Sayed, M G et al. (2001). Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nature Genetics, 28 184-187.
67. Woodford-Richens, K, Williamson, J, Bevan, S et al. (2000). Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. Cancer Research, 60 2477-2482.
68. Coburn, M C, Pricolo, V E, DeLuca, F G et al. (1995). Malignant potential in intestinal juvenile polyposis syndromes. Annals of Surgical Oncology, 2 386-391.
69. Woodford-Richens, K, Bevan, S, Churchman, M et al. (2000). Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut, 46 656-660.
70. Howe, J R, Mitros, F A, & Summers, R W (1998). The risk of gastrointestinal carcinoma in familial juvenile polyposis. Annals of Surgical Oncology, 5 751-756.
71. Walpole, I R, & Cullity, G (1989). Juvenile polyposis: a case with early presentation and death attributable to adenocarcinoma of the pancreas. American Journal of Medical Genetics, 32 1-8.
72. Thun, M J, Namboodiri, M M, & Heath, Jr. C W (1991). Aspirin use and reduced risk of fatal colon cancer. New England Journal of Medicine, 325 1593-1596.
73. Giovannucci, E, Rimm, E B, Stampfer, M J et al. (1994). Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Annals of Internal Medicine, 121 241-246.
74. Giovannucci, E, Egan, K M, Hunter, D J et al. (1995). Aspirin and the risk of colorectal cancer in women. New England Journal of Medicine, 333 609-614.
75. Gann, P H, Manson, J E, Glynn, R J et al. (1993). Low-dose aspirin and incidence of colorectal tumors in a randomized trial. Journal of the National Cancer Institute, 85 1220-1224.
76. Stürmer, T, Glynn, R J, Lee, I M et al. (1998). Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Annals of Internal Medicine, 128 713-720.
77. Giovannucci, E, Stampfer, M J, Colditz, G A et al. (1993). Folate, methionine, and alcohol intake and risk of colorectal adenoma. Journal of the National Cancer Institute, 85 875-884.
78. Giovannucci, E, Stampfer, M J, Colditz, G A et al. (1998). Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Annals of Internal Medicine, 129 517-524.
79. Baron, J A, Beach, M, Mandel, J S et al. (1999). Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. New England Journal of Medicine, 340 101-107.
80. Calle, E E, Miracle-McMahill, H L, Thun, M J, & Heath, Jr. C W (1995). Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. Journal of the National Cancer Institute, 87 517-523.
81. Grodstein, F, Martinez, M E, Platz, E A et al. (1998). Postmenopausal hormone use and risk for colorectal cancer and adenoma. Annals of Internal Medicine, 128 705-712.
82. Schulmann, K, Schmiegel, W, Kolorektales Karzinom, In Ganten, D, Ruckpaul, K, Hahn, SA, Schmiegel, W, (Eds.), Molekulargenetische Grundlagen von nicht-hereditären Tumorerkrankungen, Berlin, Heidelberg, New York, Tokyo, Springer (at press)